New White Paper - Read AAM Report on Drug Shortages
  • Sanjeev Krishnan​ – President, North America, Glenmark Pharmaceuticals, Inc, USA
    “AAM membership is an investment in our business.”
    Sanjeev Krishan
    President, North America, Glenmark Pharmaceuticals, Inc, USA
  • “AAM is my ‘go-to’ source—just a phone call away—when I need information about a legislative issue.”
    Keren Haruvi
    President, Sandoz US, Head of North America
  • John Ducker – President and Chief Executive Officer, Fresenius Kabi USA, LLC
    “The association wrote formal comments to FDA rulemakings that represented our company’s views. This was very helpful.”
    John Ducker
    President and Chief Executive Officer, Fresenius Kabi USA, LLC
  • David Gaugh – Senior Vice President, Sciences & Regulatory Affairs, Association for Accessible Medicines
    “As a member of AAM, your regulatory and quality staff can be an integral voice on our member working groups.”
    David Gaugh
    Interm CEO, Association for Accessible Medicines

Join AAM

As the unifying and organizing force within the generics and biosimilars industry, AAM advocates on behalf of our members, supporting and protecting their ability to thrive and innovate.

Investing in AAM or Biosimilars Council membership empowers you to chart a smart course for your business. New legislation and regulations are introduced all the time. Pressure is building to substantially revise supply chains. Brand-name manufacturers continue to use every tool at their disposal to retain monopoly rights past the original expiration date.​

About AAM Membership
About AAM Membership Flyer

When your company invests in membership, we amplify your voice and advocate for your interests.

Benefits of membership include:

  • A seat at the table with other industry leaders to guide association priorities
  • Direct face-to-face interactions with key decision-makers and policymakers in DC
  • Access to the expertise of seasoned lobbyists and industry veterans​ 
  • Discounts on events and meetings​
  • Actionable information about the latest news and state of the industry

Download AAM Regular Membership Flyer


Join AAM, your association for generic and biosimilar medicines. No matter where you are in the product life cycle, AAM has a corporate membership option for you. Our team is here to assist in choosing the level of membership that makes sense, view AAM Membership Categories and Dues.

AAM membership is company based; AAM does not offer individual memberships. If you would like to sign up for our newsletter you can subscribe to our monthly AAM eNews or Biosimilars Bulletin.

One-year introductory memberships are now available for qualified organizations.​

Please fill out the form below for more information.

Association for Accessible Medicines


Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.